医学
丙型肝炎病毒
肝炎病毒
内科学
临床试验
重症监护医学
肿瘤科
丙型肝炎
临床肿瘤学
病毒
癌症
肝炎
病毒学
作者
Sobia N. Laique,Hugo E. Vargas
标识
DOI:10.14309/ajg.0000000000000095
摘要
Abstract: Historically, hepatitis C virus infection has posed a barrier to cancer therapies and enrollment in clinical trials for oncology patients. Oral direct acting antivirals now allow most patients, previously considered difficult to treat to be effectively (>95% sustained virologic response) and safely cured.
科研通智能强力驱动
Strongly Powered by AbleSci AI